Cardiology’s Gatekeeper to Vet Digital Health in Landmark Collaboration

MENLO PARK, CA – March 03, 2026 – In a move that could reshape the future of preventive cardiovascular medicine, the American College of Cardiology (ACC) has entered a strategic collaboration with digital health platform Hello Heart. The partnership will see the influential medical society convene an independent clinician workgroup to rigorously evaluate Hello Heart’s technology, a step that signals a potential turning point for the integration of digital tools into standard clinical practice.

Cardiovascular disease remains the leading cause of death in the United States, affecting over 126 million Americans. This collaboration aims to directly address this crisis by advancing the responsible use of digital innovation to improve patient outcomes and expand access to care. As part of the agreement, Hello Heart will also join the ACC’s Industry Advisory Forum, contributing to high-level discussions on the future of heart care, from policy to quality improvement.

The core of the initiative involves a deep clinical assessment. The ACC’s workgroup will scrutinize Hello Heart’s entire ecosystem, including its cardiovascular monitoring technology, AI-driven coaching, clinician-facing reports, and its integration capabilities with electronic medical records (EMR). The goal is to identify concrete opportunities for the platform to complement and enhance the care cardiologists provide.

“We have the potential to radically improve preventive cardiovascular care with digital innovation and artificial intelligence,” said Ami Bhatt, MD, Chief Innovation Officer at the American College of Cardiology. “Collaborations that thoughtfully evaluate emerging technologies and explore their practical integration into clinical workflows are essential to improving patient outcomes outside of the clinic and supporting clinicians in delivering high-quality, guideline-directed care.”

Bridging the Gap Between Innovation and Clinical Trust

The ACC's involvement lends significant weight to a digital health sector often struggling to prove its clinical utility. As the preeminent professional organization for cardiovascular specialists, the ACC sets the standards for care through its influential guidelines and educational programs. Its decision to formally evaluate a commercial digital platform marks a critical step towards validating such tools and moving them from the periphery to the center of patient management.

This collaboration aligns with the ACC’s established “Innovation Roadmap,” a strategic framework designed to guide the adoption of digital health, big data, and precision medicine. The organization has long advocated for an evidence-based approach, creating a “Best Practices for Consumer Cardiovascular Technology Solutions” framework that assesses tools based on ease of use, accuracy, clinical outcomes, and workflow integration. This partnership puts that framework into action, providing a real-world test case for how a leading medical body can shepherd new technology into the clinical fold responsibly.

For digital health companies, earning the trust of clinicians is the ultimate hurdle. Many physicians remain skeptical, burned by past technology implementations like early EMRs that increased administrative burdens and led to “alarm fatigue.” By bringing an independent workgroup of clinicians to the table, this collaboration directly addresses those concerns, seeking to ensure that Hello Heart’s platform is not just another source of data, but a truly complementary tool that provides actionable insights.

“Digital health programs must be clinically rigorous, evidence-based, and complementary to high-quality care,” stated Colleen Pietras, MD, VP of Medical Affairs at Hello Heart. “Working alongside the American College of Cardiology allows us to further strengthen the clinical foundation of Hello Heart’s platform and ensure we are aligned with the needs of cardiologists, health systems and the patients they serve.”

The Evidence Behind the App

Hello Heart comes to the collaboration armed with a growing body of peer-reviewed evidence suggesting its platform can drive meaningful clinical and economic outcomes. The company’s approach combines a connected heart monitor, pill box, and a smartphone app that uses AI and behavioral science to help users manage their blood pressure, cholesterol, and weight.

A large-scale study published in the Journal of the American Heart Association (JAHA) in May 2024 provided substantial support for the program's effectiveness. Analyzing data from over 100,000 users, the study found that participants with dangerously high baseline systolic blood pressure (above 140 mmHg) achieved an average reduction of 19 mmHg over two years. The results were similarly impressive for cholesterol management, with users who had high baseline LDL-C (above 160 mg/dL) seeing an average reduction of 67 mg/dL within 13 months.

Beyond clinical metrics, the platform has demonstrated significant economic benefits. A peer-reviewed study in the journal Value in Health reported annual cost savings of $1,709 per participant compared to a matched control group, a figure attributed in part to a 47% reduction in inpatient hospital days. An independent analysis by Aon further bolstered these findings, reporting an average medical cost reduction of $1,434 per member per year for program participants.

These results, particularly among high-risk and older populations, provide a compelling foundation for the ACC’s evaluation. The workgroup’s task will be to assess the robustness of this data and determine how these user-generated health improvements can be best leveraged within a formal clinical setting to support guideline-directed medical therapy.

A New Prescription for Cardiologists?

The proliferation of digital health tools, from remote patient monitoring (RPM) devices like AliveCor's KardiaMobile to comprehensive platforms like Hello Heart and its competitors Omada and Livongo, presents both an opportunity and a challenge for healthcare systems. The potential to gather real-time patient data promises a shift from episodic to continuous, proactive care. However, this data deluge can overwhelm clinicians if not properly filtered and integrated.

Seamless EMR integration is a cornerstone of this collaboration's focus. For digital health to succeed, it cannot operate in a silo. Data from a patient's home blood pressure readings must flow seamlessly into their official health record, and insights must be presented to clinicians in a way that informs, rather than complicates, their decision-making process. The ACC workgroup's evaluation of Hello Heart's EMR integration will be a critical test of its practicality in a busy clinical environment.

The partnership also reflects a broader trend in which medical bodies are becoming more proactive in guiding technological innovation. Rather than waiting for technologies to mature and then reacting, the ACC is taking a hands-on role to ensure new tools are developed with clinical needs at the forefront. This collaborative model could provide a blueprint for how to navigate the delicate balance between embracing innovation and maintaining the rigorous standards of evidence-based medicine. By focusing on workflow, data utility, and clinical outcomes, this evaluation could help define what makes a digital health tool not just innovative, but indispensable for modern cardiology. This partnership could ultimately define the pathway for how future digital health innovations earn their place within the standard of care.